These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 33374313)

  • 1. Paraoxonase Role in Human Neurodegenerative Diseases.
    Reichert CO; Levy D; Bydlowski SP
    Antioxidants (Basel); 2020 Dec; 10(1):. PubMed ID: 33374313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signature of paraoxonases in the altered redox homeostasis in Alzheimer's disease.
    Beggiato S; Ferrara F; Romani A; Cassano T; Trentini A; Valacchi G; Cervellati C; Ferraro L
    Chem Biol Interact; 2024 Jan; 388():110839. PubMed ID: 38142921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview.
    Levy D; Reichert CO; Bydlowski SP
    Antioxidants (Basel); 2019 May; 8(5):. PubMed ID: 31052559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, infection, cancer and all that…the role of paraoxonases.
    Devarajan A; Shih D; Reddy ST
    Adv Exp Med Biol; 2014; 824():33-41. PubMed ID: 25038992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease.
    Mohammed CJ; Lamichhane S; Connolly JA; Soehnlen SM; Khalaf FK; Malhotra D; Haller ST; Isailovic D; Kennedy DJ
    Antioxidants (Basel); 2022 Mar; 11(3):. PubMed ID: 35326240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonases at the Heart of Neurological Disorders.
    Khalaf FK; Connolly J; Khatib-Shahidi B; Albehadili A; Tassavvor I; Ranabothu M; Eid N; Dube P; Khouri SJ; Malhotra D; Haller ST; Kennedy DJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
    Taler-Verčič A; Goličnik M; Bavec A
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2.
    Shamir R; Hartman C; Karry R; Pavlotzky E; Eliakim R; Lachter J; Suissa A; Aviram M
    Free Radic Biol Med; 2005 Aug; 39(3):336-44. PubMed ID: 15993332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.
    Salari N; Rasoulpoor S; Hosseinian-Far A; Razazian N; Mansouri K; Mohammadi M; Vaisi-Raygani A; Jalali R; Shabani S
    Neurol Sci; 2021 Feb; 42(2):491-500. PubMed ID: 33095366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data.
    Li YR; Zhu H; Kauffman M; Danelisen I; Misra HP; Ke Y; Jia Z
    Exp Biol Med (Maywood); 2014 Aug; 239(8):899-906. PubMed ID: 24903163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body].
    Borovkova EI; Antipova NV; Komeenko TV; Shakhparonov MI; Borovkov IM
    Vestn Ross Akad Med Nauk; 2017; 72(1):5-10. PubMed ID: 29308836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods.
    Barathi S; Charanya M; Muthukumaran S; Angayarkanni N; Umashankar V
    J Ocul Biol Dis Infor; 2010 Jun; 3(2):64-72. PubMed ID: 22319641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
    Castellazzi M; Trentini A; Romani A; Valacchi G; Bellini T; Bonaccorsi G; Fainardi E; Cavicchio C; Passaro A; Zuliani G; Cervellati C
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):356-363. PubMed ID: 27312742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase gene polymorphisms and sporadic ALS.
    Slowik A; Tomik B; Wolkow PP; Partyka D; Turaj W; Malecki MT; Pera J; Dziedzic T; Szczudlik A; Figlewicz DA
    Neurology; 2006 Sep; 67(5):766-70. PubMed ID: 16822965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.